This week was packed with new product launches. From the long-awaited debut of Pokémon Legends: Z-A to the first luggage with built-in Apple Find My tracking from July and even a new Ninja Crispi Pro ...

“Gen Z are more likely to make purchase decisions on reviews and the number of reviews a product and/or service has,” Kevin ...

The list of kitchen gadgets available these days seems endless, and some of them can be seen as upscale or frivolous. For Gen Z, this appliance is a must-have.

Youssi Custom Homes of Iowa has expanded its residential portfolio at Forest Grove Crossing, introducing multiple housing configurations to meet growing demand in the Quad Cities region. The expansion ...

At a glance Expert's Rating Pros ・DIY installation option can save you lots of money ・Trusted Neighbor is a great feature ・Nest cameras and video doorbell support facial recognition and can ...

NewHomeSource reports Boomers and Millennials have distinct homebuying preferences: Boomers seek low-maintenance, traditional ...

“Picket Line,” which was inspired by Cesar Chavez and his union campaigns, has been published for the first time. By Héctor Tobar Héctor Tobar’s next novel, about the future and present of Los Angeles ...

I've tested everything from TVs to phones, PCs, tablets and more. With an enhanced clamshell design and a smart software integration, the Samsung Galaxy Z Flip 7 phone promises to help busy ...

The City Council overwhelmingly approved new rules for installing appliances on Thursday despite critics arguing the mandates would mean higher costs for building owners — and larger rent bills.

Goodspeed Musicals is dedicated not only to staging great American musicals but studying them, building upon them and figuring out what makes them tick. That’s what makes the theater’s new production ...

Enhertu plus Perjeta received FDA priority review for first-line treatment of HER2-positive metastatic breast cancer, showing significant improvements in progression-free survival and response rates.

A regulatory decision is expected during the first quarter of 2026. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for ...